IBDEI36R ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,50866,1,3,0)
;;=3^Family Hx of Malig Neop of Testis
;;^UTILITY(U,$J,358.3,50866,1,4,0)
;;=4^Z80.43
;;^UTILITY(U,$J,358.3,50866,2)
;;=^5063350
;;^UTILITY(U,$J,358.3,50867,0)
;;=Z80.6^^193^2498^25
;;^UTILITY(U,$J,358.3,50867,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50867,1,3,0)
;;=3^Family Hx of Leukemia
;;^UTILITY(U,$J,358.3,50867,1,4,0)
;;=4^Z80.6
;;^UTILITY(U,$J,358.3,50867,2)
;;=^5063354
;;^UTILITY(U,$J,358.3,50868,0)
;;=Z80.8^^193^2498^30
;;^UTILITY(U,$J,358.3,50868,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50868,1,3,0)
;;=3^Family Hx of Malig Neop of Organs/Systems
;;^UTILITY(U,$J,358.3,50868,1,4,0)
;;=4^Z80.8
;;^UTILITY(U,$J,358.3,50868,2)
;;=^5063356
;;^UTILITY(U,$J,358.3,50869,0)
;;=Z81.8^^193^2498^35
;;^UTILITY(U,$J,358.3,50869,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50869,1,3,0)
;;=3^Family Hx of Mental/Behavioral Disorders
;;^UTILITY(U,$J,358.3,50869,1,4,0)
;;=4^Z81.8
;;^UTILITY(U,$J,358.3,50869,2)
;;=^5063363
;;^UTILITY(U,$J,358.3,50870,0)
;;=Z82.3^^193^2498^42
;;^UTILITY(U,$J,358.3,50870,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50870,1,3,0)
;;=3^Family Hx of Stroke
;;^UTILITY(U,$J,358.3,50870,1,4,0)
;;=4^Z82.3
;;^UTILITY(U,$J,358.3,50870,2)
;;=^5063367
;;^UTILITY(U,$J,358.3,50871,0)
;;=Z82.49^^193^2498^24
;;^UTILITY(U,$J,358.3,50871,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50871,1,3,0)
;;=3^Family Hx of Ischemic Heart Disease/Circulatory System
;;^UTILITY(U,$J,358.3,50871,1,4,0)
;;=4^Z82.49
;;^UTILITY(U,$J,358.3,50871,2)
;;=^5063369
;;^UTILITY(U,$J,358.3,50872,0)
;;=Z82.5^^193^2498^14
;;^UTILITY(U,$J,358.3,50872,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50872,1,3,0)
;;=3^Family Hx of Asthma/Chronic Lower Respiratory Diseases
;;^UTILITY(U,$J,358.3,50872,1,4,0)
;;=4^Z82.5
;;^UTILITY(U,$J,358.3,50872,2)
;;=^5063370
;;^UTILITY(U,$J,358.3,50873,0)
;;=Z82.61^^193^2498^13
;;^UTILITY(U,$J,358.3,50873,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50873,1,3,0)
;;=3^Family Hx of Arthritis
;;^UTILITY(U,$J,358.3,50873,1,4,0)
;;=4^Z82.61
;;^UTILITY(U,$J,358.3,50873,2)
;;=^5063371
;;^UTILITY(U,$J,358.3,50874,0)
;;=Z82.69^^193^2498^37
;;^UTILITY(U,$J,358.3,50874,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50874,1,3,0)
;;=3^Family Hx of Musculoskeletal System/Connective Tissue
;;^UTILITY(U,$J,358.3,50874,1,4,0)
;;=4^Z82.69
;;^UTILITY(U,$J,358.3,50874,2)
;;=^5063373
;;^UTILITY(U,$J,358.3,50875,0)
;;=Z83.3^^193^2498^20
;;^UTILITY(U,$J,358.3,50875,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50875,1,3,0)
;;=3^Family Hx of Diabetes Mellitus
;;^UTILITY(U,$J,358.3,50875,1,4,0)
;;=4^Z83.3
;;^UTILITY(U,$J,358.3,50875,2)
;;=^5063379
;;^UTILITY(U,$J,358.3,50876,0)
;;=Z83.2^^193^2498^16
;;^UTILITY(U,$J,358.3,50876,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50876,1,3,0)
;;=3^Family Hx of Blood/Immune Mechanism Diseases
;;^UTILITY(U,$J,358.3,50876,1,4,0)
;;=4^Z83.2
;;^UTILITY(U,$J,358.3,50876,2)
;;=^5063378
;;^UTILITY(U,$J,358.3,50877,0)
;;=Z82.71^^193^2498^40
;;^UTILITY(U,$J,358.3,50877,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50877,1,3,0)
;;=3^Family Hx of Polycystic Kidney
;;^UTILITY(U,$J,358.3,50877,1,4,0)
;;=4^Z82.71
;;^UTILITY(U,$J,358.3,50877,2)
;;=^321531
;;^UTILITY(U,$J,358.3,50878,0)
;;=Z82.1^^193^2498^15
;;^UTILITY(U,$J,358.3,50878,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50878,1,3,0)
;;=3^Family Hx of Blindness/Visual Loss
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI36R 3820 printed Dec 13, 2024@02:42:54 Page 2
IBDEI36R ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,50866,1,3,0)
+2 ;;=3^Family Hx of Malig Neop of Testis
+3 ;;^UTILITY(U,$J,358.3,50866,1,4,0)
+4 ;;=4^Z80.43
+5 ;;^UTILITY(U,$J,358.3,50866,2)
+6 ;;=^5063350
+7 ;;^UTILITY(U,$J,358.3,50867,0)
+8 ;;=Z80.6^^193^2498^25
+9 ;;^UTILITY(U,$J,358.3,50867,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,50867,1,3,0)
+12 ;;=3^Family Hx of Leukemia
+13 ;;^UTILITY(U,$J,358.3,50867,1,4,0)
+14 ;;=4^Z80.6
+15 ;;^UTILITY(U,$J,358.3,50867,2)
+16 ;;=^5063354
+17 ;;^UTILITY(U,$J,358.3,50868,0)
+18 ;;=Z80.8^^193^2498^30
+19 ;;^UTILITY(U,$J,358.3,50868,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,50868,1,3,0)
+22 ;;=3^Family Hx of Malig Neop of Organs/Systems
+23 ;;^UTILITY(U,$J,358.3,50868,1,4,0)
+24 ;;=4^Z80.8
+25 ;;^UTILITY(U,$J,358.3,50868,2)
+26 ;;=^5063356
+27 ;;^UTILITY(U,$J,358.3,50869,0)
+28 ;;=Z81.8^^193^2498^35
+29 ;;^UTILITY(U,$J,358.3,50869,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,50869,1,3,0)
+32 ;;=3^Family Hx of Mental/Behavioral Disorders
+33 ;;^UTILITY(U,$J,358.3,50869,1,4,0)
+34 ;;=4^Z81.8
+35 ;;^UTILITY(U,$J,358.3,50869,2)
+36 ;;=^5063363
+37 ;;^UTILITY(U,$J,358.3,50870,0)
+38 ;;=Z82.3^^193^2498^42
+39 ;;^UTILITY(U,$J,358.3,50870,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,50870,1,3,0)
+42 ;;=3^Family Hx of Stroke
+43 ;;^UTILITY(U,$J,358.3,50870,1,4,0)
+44 ;;=4^Z82.3
+45 ;;^UTILITY(U,$J,358.3,50870,2)
+46 ;;=^5063367
+47 ;;^UTILITY(U,$J,358.3,50871,0)
+48 ;;=Z82.49^^193^2498^24
+49 ;;^UTILITY(U,$J,358.3,50871,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,50871,1,3,0)
+52 ;;=3^Family Hx of Ischemic Heart Disease/Circulatory System
+53 ;;^UTILITY(U,$J,358.3,50871,1,4,0)
+54 ;;=4^Z82.49
+55 ;;^UTILITY(U,$J,358.3,50871,2)
+56 ;;=^5063369
+57 ;;^UTILITY(U,$J,358.3,50872,0)
+58 ;;=Z82.5^^193^2498^14
+59 ;;^UTILITY(U,$J,358.3,50872,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,50872,1,3,0)
+62 ;;=3^Family Hx of Asthma/Chronic Lower Respiratory Diseases
+63 ;;^UTILITY(U,$J,358.3,50872,1,4,0)
+64 ;;=4^Z82.5
+65 ;;^UTILITY(U,$J,358.3,50872,2)
+66 ;;=^5063370
+67 ;;^UTILITY(U,$J,358.3,50873,0)
+68 ;;=Z82.61^^193^2498^13
+69 ;;^UTILITY(U,$J,358.3,50873,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,50873,1,3,0)
+72 ;;=3^Family Hx of Arthritis
+73 ;;^UTILITY(U,$J,358.3,50873,1,4,0)
+74 ;;=4^Z82.61
+75 ;;^UTILITY(U,$J,358.3,50873,2)
+76 ;;=^5063371
+77 ;;^UTILITY(U,$J,358.3,50874,0)
+78 ;;=Z82.69^^193^2498^37
+79 ;;^UTILITY(U,$J,358.3,50874,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,50874,1,3,0)
+82 ;;=3^Family Hx of Musculoskeletal System/Connective Tissue
+83 ;;^UTILITY(U,$J,358.3,50874,1,4,0)
+84 ;;=4^Z82.69
+85 ;;^UTILITY(U,$J,358.3,50874,2)
+86 ;;=^5063373
+87 ;;^UTILITY(U,$J,358.3,50875,0)
+88 ;;=Z83.3^^193^2498^20
+89 ;;^UTILITY(U,$J,358.3,50875,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,50875,1,3,0)
+92 ;;=3^Family Hx of Diabetes Mellitus
+93 ;;^UTILITY(U,$J,358.3,50875,1,4,0)
+94 ;;=4^Z83.3
+95 ;;^UTILITY(U,$J,358.3,50875,2)
+96 ;;=^5063379
+97 ;;^UTILITY(U,$J,358.3,50876,0)
+98 ;;=Z83.2^^193^2498^16
+99 ;;^UTILITY(U,$J,358.3,50876,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,50876,1,3,0)
+102 ;;=3^Family Hx of Blood/Immune Mechanism Diseases
+103 ;;^UTILITY(U,$J,358.3,50876,1,4,0)
+104 ;;=4^Z83.2
+105 ;;^UTILITY(U,$J,358.3,50876,2)
+106 ;;=^5063378
+107 ;;^UTILITY(U,$J,358.3,50877,0)
+108 ;;=Z82.71^^193^2498^40
+109 ;;^UTILITY(U,$J,358.3,50877,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,50877,1,3,0)
+112 ;;=3^Family Hx of Polycystic Kidney
+113 ;;^UTILITY(U,$J,358.3,50877,1,4,0)
+114 ;;=4^Z82.71
+115 ;;^UTILITY(U,$J,358.3,50877,2)
+116 ;;=^321531
+117 ;;^UTILITY(U,$J,358.3,50878,0)
+118 ;;=Z82.1^^193^2498^15
+119 ;;^UTILITY(U,$J,358.3,50878,1,0)
+120 ;;=^358.31IA^4^2
+121 ;;^UTILITY(U,$J,358.3,50878,1,3,0)
+122 ;;=3^Family Hx of Blindness/Visual Loss
